Very cool #flozin trial in JASN
N = 14 with SIAD crossover with placebo/Empagliflozin
https://jasn.asnjournals.org/content/early/2022/11/16/ASN.2022050623
cc @ChristosArgyrop @Kidney_boy
Do we need a larger trial, or is this enough? #hyponatremia #nephrology
@ChristosArgyrop @Kidney_boy
Without reading the paper, guess what the last panel on the right means
@hswapnil
? before intervention, he/she had so many queries, but now after sglt2i, he/she is blissfully unaware/ very less no.of questions.
@raghumullapillil @hswapnil most but not all questions were answered
@DrWeintraub @raghumullapillil nice tries!
I suspect they are describing the change in cognition (MoCA) - see below
@Kidney_boy @hswapnil @ChristosArgyrop interesting data even without the last panel. What was the care in the placebo group? Did it include fluid restriction?
@DrWeintraub @Kidney_boy @ChristosArgyrop yes both groups were told to restrict fluid (< 1.5 litres)
@hswapnil @ChristosArgyrop They are so bad at visual abstracts it hurts.